JAK inhibition reduces SARS-CoV-2 liver infectivity and modulates inflammatory responses to reduce morbidity and mortality
scientific article published on 13 November 2020
Author/s
author: Justin Stebbing, Ginés Sánchez Nievas, Sonia Youhanna, Silvia Ottaviani, Christian Sommerauer, Fabio Monzani, Francesco Forfori, Salvatore De Marco, Fabio Lena, Leonardo Gianluca Lacerenza, Cesira Nencioni, David Caldevilla-Bernardo, Daniela Matarrese, Delia Goletti, Yee-Joo Tan, Vanessa Monteil, Alessio Farcomeni, Shuchismita Dutta, Haibo Zhang, Mauro Pistello, William Li, Rafael García-Molina, Claudia Kutter, James Felce, Zehra F Nizami, Josef Penninger, Pedro Abizanda, Volker M. Lauschke, George Dranitsaris